leisure time -WSS

leisure time

author：hotspot 2025-08-28 08:39:46 - browse：29276

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Hollywood unions extend contract negotiations for actors
Next article： How AI can help patients find reliable information about doctors

WSS

STAT Readout Newsletter: Biotech news today

STAT Summit: Ending the crisis of Black deaths in the U.S.

STAT Summit: Ending the crisis of Black deaths in the U.S.

STAT Summit: How researchers deal with rejection

CZI to create biohub to build anti

Why a market frenzy over new weight loss drugs defies logic

leisure time

leisure time

focus

Drug repurposing or repositioning? The language matters

STAT Summit: Ending the crisis of Black deaths in the U.S.

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD podcast: Live from the 2023 STAT Summit

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Study on Amgen’s bispecific immunotherapy produces positive data

What does generative AI mean for health care? We asked experts

CZI to create biohub to build anti

Continuity nursing helped my family in our darkest PICU moments

Roche drug slashes death risk in early

Wikipedia

STAT Readout: Friday, Oct. 20 biotech updates

ADCs take center stage as promising cancer treatments

Roivant's CEO is a star, but biotech's black hole persists

STAT Summit: Meghan O’Rourke on making chronic illness visible

Why a market frenzy over new weight loss drugs defies logic

STAT Summit: Ending the crisis of Black deaths in the U.S.

hotspot

knowledge

entertainment

entertainment